510(k) K974811
K974811 is an FDA 510(k) premarket notification submitted by Boston Biomedica, Inc. for the device "ACCURUN(TM) 150 HSV IGG POSITIVE CONTROL". The FDA issued a decision of Substantially Equivalent on February 10, 1998. The device falls under product code JJX (Single (Specified) Analyte Controls (Assayed And Unassayed)), a Class I device regulated under 21 CFR 862.1660. Boston Biomedica, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- February 10, 1998
- Date Received
- December 23, 1997
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Single (Specified) Analyte Controls (Assayed And Unassayed)
- Device Class
- Class I
- Regulation Number
- 862.1660
- Review Panel
- CH
- Submission Type